[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.90.95. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 409
Citations 0
Lab Reports
September 1, 2015

Novel, Long-Acting Drug May Help Prevent and Treat Malaria

JAMA. 2015;314(9):866. doi:10.1001/jama.2015.9802

An international team of scientists has developed a compound that looks promising as a novel antimalarial agent. The compound targets dihydroorotate dehydrogenase (DHODH), an enzyme involved in the Plasmodium parasite’s de novo production of pyrimidines required for nucleic acid synthesis (Phillips MA et al. Sci Transl Med. 2015;7[296]:296ra111).

DSM265, named after several of the collaborators’ cities (Dallas, Seattle, and Melbourne), was the 265th version of an initial compound targeting DHODH, and is highly selective toward the Plasmodium falciparum—but not the human—form of the enzyme.

First Page Preview View Large
First page PDF preview
First page PDF preview
×